Secondary Logo

Journal Logo

Erratum

Erratum

doi: 10.1097/GME.0000000000000957
  • Free

In multiple issues of Menopause, several articles and abstracts regarding information published about the FRAX osteoporotic fracture tool and the World Health Organization (WHO) were incorrect. FRAX was developed by researchers at the University of Sheffield; although the department was designated as a WHO Collaborating Centre, this tool was not developed nor endorsed by WHO.

WHO has asked us to correct the public record (supplemental content 1, https://links.lww.com/MENO/A255). They have further explained that:

  • The FRAX tool is not a “WHO tool”;
  • The FRAX tool was/is not developed, endorsed, evaluated or validated by WHO; and
  • The University of Sheffield, including its Metabolic Bone Disease Unit, has not been a WHO Collaborating Centre since January 2010

WHO published a full statement about this matter in the Editorial “Clarifying WHO's position on the FRAX tool for fracture prediction” in Bulletin of the World Health Organization 2016;94:862. doi: http://dx.doi.org/10.2471/BLT.16.188532.

The Menopause articles to be corrected by this erratum are:

  • 1. In the article appearing in Volume 22, pages 75-78, titled “Can the FRAX tool be a useful aid for clinicians in referring women for periodontal care?,” the section Abstract Objective and page 76 (left column, first full paragraph), should have expanded the FRAX tool as follows:
    • a. This study aims to compare periodontitis severity in postmenopausal women whose FRAX (Fracture Risk Assessment Tool) scores indicate a major risk for osteoporotic fracture (OPF) versus controls.
    • b. As such, there is currently no predictive algorithm for predicting periodontitis in PMW with osteoporosis in the way that FRAX tool (Fracture Risk Assessment Tool) predicts osteoporotic fracture (OPF) in women at risk for postmenopausal skeletal bone loss.
  • 2. In the article appearing in Volume 15, pages 1023-1026, titled “A personal perspective on fracture risk assessment tools,” the section Abstract; page 1023 (left column, first paragraph); Figure 1; and page 1025 (right column, last paragraph) should have appeared as follows:
    • a. The Centre for Metabolic Bone Diseases (University of Sheffield, UK) and the Foundation for Osteoporosis Research and Education have each recently posted fracture risk assessment tools on Websites.
    • b. In this light, let me share my perspective on two recently posted Web-based fracture tools, the University of Sheffield‘s FRAX (http://www.shef.ac.uk/FRAX) and the Foundation for Osteoporosis and Education‘s FRC (http://riskcalculator.fore.org).
    • c. Figure 1 image website banner “FRAX Fracture Risk Assessment Tool.”
    • d. However, FRAX was circumscribed in its creative efforts; the tool was never intended to stand alone, but was expected to feed into local decision aids based on national norms and available resources.
  • 2. Additionally, there are six meeting abstracts published in Menopause that are included in this correction to the record:
  • 3. In the abstract appearing in Volume 16, page 1232, the section Plenary Symposium #3, titled “Update on current and future osteoporosis treatments,” line 6, should not reference FRAX as developed by WHO.
  • 4. In the abstract appearing in Volume 22, page 1392, abstract P-61, titled “Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures: a systematic review and meta-analysis,” section Objective, line 1, should not reference FRAX as a WHO tool.
  • 5. In the abstract appearing in Volume 17, page 1211, the section Plenary Symposium #3, titled “FRAX update: issues in practice,” line 11, should not reference FRAX as developed by WHO.
  • 6. In the abstract appearing in Volume 16, page 1232, the section Plenary Symposium #3, titled “Osteoporosis and fracture risk assessment,” line 15, should not reference FRAX as a WHO tool.
  • 7. In the abstract appearing in Volume 17, page 1211-1212, the section Plenary Symposium #4, titled “Postmenopausal osteoporosis: selecting appropriate prescription therapy for individual patients,” line 5, should not reference FRAX as developed by WHO.
  • 8. In the abstract appearing in Volume 17, page 1211, the section Plenary Symposium #3, titled “New NOF guidelines,” lines 3 and 25, should not reference FRAX as developed by WHO or as a WHO tool.

REFERENCES

1. Alli F, Bhandal GK, Thacker HL, Palomo L. Can the FRAX tool be a useful aid for clinicians in referring women for periodontal care? Menopause 2015; 22:75–78.
2. Ettinger B. A personal perspective on fracture risk assessment tools. Menopause 2008; 15:1023–1026.
3. Harris ST. Update on current and future osteoporosis treatments [Abstract]. 20th Annual Meeting of The North American Menopause Society: September 30–October 3, 2009, San Diego, CA; Plenary Symposium #3. Menopause 2009; 16:1232.
4. Jiang X, Gruner M, Trémollieres F, et al. Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures: a systematic review and meta-analysis [Abstract P-61]. 26th Annual Meeting of The North American Menopause Society: September 30–October 3, 2015, Las Vegas, NV. Menopause 2015; 22:1392.
5. Luckey MM. FRAX update: issues in practice [Abstract]. 21st Annual Meeting of The North American Menopause Society: October 6–October 9, 2010, Chicago, IL; Plenary Symposium #3. Menopause 2010; 17:1211.
6. Schneider DL. Osteoporosis and fracture risk assessment [Abstract]. 20th Annual Meeting of The North American Menopause Society: September 30–October 3, 2009, San Diego, CA; Plenary Symposium #3. Menopause 2009; 16:1232.
7. Watts NB. Postmenopausal osteoporosis: selecting appropriate prescription therapy for individual patients [Abstract]. 21st Annual Meeting of The North American Menopause Society: October 6–October 9, 2010, Chicago, IL; Plenary Symposium #4. Menopause 2010; 17:1211–1212.
8. Dawson-Hughes B. New NOF guidelines [Abstract]. 21st Annual Meeting of The North American Menopause Society: October 6–October 9, 2010, Chicago, IL; Plenary Symposium #3. Menopause 2010; 17:1211.

Supplemental Digital Content

© 2017 by The North American Menopause Society